3SBio Financial Statements
3SBio Financial Information
| Company Type | Public |
|---|---|
| Fiscal Year-End | December |
This data is provided as per license from EDGAR Online
3SBio Income Statement
| 2006 | 2005 | 2004 | |
|---|---|---|---|
| Revenue ($ mil.) | 16.4 | 12.9 | 9.3 |
| Gross Profit ($ mil.) | 14.9 | 10.9 | 7.5 |
| Operating Income ($ mil.) | 4.7 | 2.5 | 0.7 |
| Total Net Income ($ mil.) | 3.9 | 2.0 | 0.8 |
| Diluted EPS (Net Income) | -- | -- | -- |
3SBio Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 0.00 | 3.88 | 1.56 |
| Price/Earnings Ratio | -- | 16.03 | 15.59 |
| Price/Book Ratio | 0.00 | 2.77 | 1.50 |
| Price/Cash Flow Ratio | 0.00 | 11.57 | 9.70 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed 3SBio Financial Ratios
3SBio Competitive Intelligence
| Hoffmann-La Roche | Kirin Holdings Company | Schering-Plough | |
|---|---|---|---|
| Annual Sales ($ mil.) | 12,884.1 | 13,986.6 | 12,690.0 |
| Employees | 5,000 | 23,332 | 55,000 |
| Market Cap ($ mil.) | -- | -- | 31,925.6 |
Competitive Landscape
